Titre:
  • Clinical guidance on evaluation and management of bone fragility in patients with monoclonal gammopathy of undetermined significance (MGUS): an IOF position statement
Auteur:Confavreux, Cyrille; Bouvard, Beatrice; Blank, Robert; Hadji, Peyman; Biver, Emmanuel; Body, Jean-Jacques; Brandi, M.L.; Campusano, Claudia; Ebeling, Peter R; Maghraoui, Abdellah El; Holzer, Gerold; Kendler, David; De Villiers, Tobie; Rizzoli, René; Foldes, Joseph A.J.
Informations sur la publication:Osteoporosis international
Statut de publication:Publié, 2026
Sujet CREF:Endocrinologie
Diabétologie
Métabolisme
Mots-clés:Bone fragility
Denosumab
DXA
MGUS
Risk factors
Zoledronic acid
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0937-941X
info:doi/10.1007/s00198-026-08178-0
info:scp/105049904353
info:pmid/42709184